Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Cardiovasc. Med., 11 September 2025

Sec. Coronary Artery Disease

Volume 12 - 2025 | https://doi.org/10.3389/fcvm.2025.1656799

Correction: Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ study

This article is a correction to:

  1. Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ study

    1. Read original article
Emeline Laurent,Emeline Laurent1,2Lucile Godillon &#x;Lucile Godillon1*†Marc-Florent Tassi,Marc-Florent Tassi1,3Pierre MarcolletPierre Marcollet4Stphan ChassaingStéphan Chassaing5Marie DecomisMarie Decomis6Julien BezinJulien Bezin7Christophe LaureChristophe Laure8Denis Angoulvant,Denis Angoulvant9,10Grgoire RangeGrégoire Range8Leslie Grammatico-Guillon, Leslie Grammatico-Guillon1,10
  • 1Public Health Unit, Epidemiology, Teaching Hospital of Tours, Tours, France
  • 2Research Unit EA 7505 “Education, Ethics and Health”, University of Tours, Tours, France
  • 3Faculty of Pharmacy, University of Tours, Tours, France
  • 4Cardiology Department, CH Bourges, Bourges, France
  • 5Cardiology Department, Private Hospital NCT+, Tours, France
  • 6Cardiology Department, Private Hospital Oréliance, Orléans, France
  • 7Clinical Pharmacology Unit, University of Bordeaux, INSERM, BPH, Team AHeaD, Bordeaux, France
  • 8Cardiology Department, Les Hôpitaux de Chartres, Chartres, France
  • 9Cardiology Department, Teaching Hospital of Tours, Tours, France
  • 10Faculty of Medicine, University of Tours, Tours, France

A Correction on

Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ study

By Laurent E, Godillon L, Tassi M-F, Marcollet P, Chassaing S, Decomis M, Bezin J, Laure C, Angoulvant D, Range G and Grammatico-Guillon L (2025). Front. Cardiovasc. Med. 12:1484401. doi: 10.3389/fcvm.2025.1484401

The figures were in the wrong order in the PDF and HTML version of this paper. Figure 2 should have been figure 3 and vice versa. The order has now been corrected.

Figure 2
Forest plot showing adjusted hazard ratios with 95 percent confidence intervals for various factors, including age over sixty-five, gender, renal impairment, diabetes, Killip class, low LVEF, no cardiac rehabilitation, and non-compliance to cardiac therapy. Renal impairment has the highest hazard ratio at approximately 2.87.

Figure 2. Factors associated with an ischemic complication and/or death at 1 year after STEMI—the STOP—SCA+ study. LVEF, left ventricular ejection fraction.

Figure 3
Forest plot showing adjusted odds ratios with 95 percent confidence intervals for various factors: age under 65 years, men, no history of myocardial infarction or coronary bypass, no stroke history, cardiac rehabilitation, and general practitioner follow-up every three months. Each factor's odds ratio exceeds 1, indicating increased likelihood associated with each condition.

Figure 3. Factors associated with compliance for the cardiac tri-therapy (PDC ≥80%) at 1 year after STEMI-the STOP-SCA+ study. TCA, transluminal coronary angioplasty; GP, general practitioner.

The original version of this article has been updated.

Generative AI statement

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: myocardial infarction (MI), cardiac rehabilitation, compliance, outcome, probabilistic matching

Citation: Laurent E, Godillon L, Tassi M-F, Marcollet P, Chassaing S, Decomis M, Bezin J, Laure C, Angoulvant D, Range G and Grammatico-Guillon L (2025) Correction: Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ study. Front. Cardiovasc. Med. 12:1656799. doi: 10.3389/fcvm.2025.1656799

Received: 30 June 2025; Accepted: 27 August 2025;
Published: 11 September 2025.

Edited and Reviewed by: Tommaso Gori, Johannes Gutenberg University Mainz, Germany

Copyright: © 2025 Laurent, Godillon, Tassi, Marcollet, Chassaing, Decomis, Bezin, Laure, Angoulvant, Range and Grammatico-Guillon. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lucile Godillon, bC5nb2RpbGxvbkBjaHUtdG91cnMuZnI=; bGVzbGllLmd1aWxsb25AdW5pdi10b3Vycy5mcg==

†ORCID:
Lucile Godillon
orcid.org/0000-0002-3852-2846

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.